|
EP3374526A1
|
|
Integration of tumor characteristics with breast cancer index
|
|
US2015329921A1
|
|
Determining tumor origin
|
|
US2015344967A1
|
|
Predicting likelihood of response to combination therapy
|
|
US2015203921A1
|
|
Predicting breast cancer recurrence
|
|
US2014349856A1
|
|
Neuroendocrine Tumors
|
|
EP2648762A2
|
|
Post-treatment breast cancer prognosis
|
|
WO2013002750A2
|
|
Determining tumor origin
|
|
WO2010088688A2
|
|
Diagnosis of in situ and invasive breast cancer
|
|
US2010047787A1
|
|
Prostate cancer survival and recurrence
|
|
EP2195467A1
|
|
Tumor grading and cancer prognosis in breast cancer
|
|
EP1670946A1
|
|
Predicting breast cancer treatment outcome
|
|
US2005239079A1
|
|
Predicting outcome with tamoxifen in breast cancer
|
